Compare GBCI & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBCI | TFX |
|---|---|---|
| Founded | 1955 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.8B |
| IPO Year | 1996 | 1994 |
| Metric | GBCI | TFX |
|---|---|---|
| Price | $43.66 | $125.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $55.83 | ★ $154.73 |
| AVG Volume (30 Days) | ★ 931.8K | 725.3K |
| Earning Date | 10-22-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.20% | 1.09% |
| EPS Growth | ★ 18.45 | N/A |
| EPS | 1.38 | ★ 2.08 |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $24.93 | $13.82 |
| Revenue Next Year | $8.32 | $4.32 |
| P/E Ratio | ★ $31.70 | $60.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.90 | $100.18 |
| 52 Week High | $54.58 | $145.00 |
| Indicator | GBCI | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 34.44 | 41.22 |
| Support Level | $43.23 | $124.49 |
| Resistance Level | $45.65 | $128.06 |
| Average True Range (ATR) | 0.83 | 3.33 |
| MACD | 0.02 | 0.22 |
| Stochastic Oscillator | 39.78 | 57.88 |
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services through its wholly owned bank subsidiary, Glacier Bank. The group provides a full range of banking services to individuals, small to medium-sized businesses, community organizations, and public entities from several locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, Nevada, and Texas. It offers various banking products and services, including: retail banking, business banking, real estate, commercial, agriculture, and consumer loans; and mortgage origination and loan servicing services, among others.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.